Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Growth · Meridian

Meridian Growth Fund Class C (MRCGX)

Ticker MRCGX · Since 2015-07-01 · · Holdings as of Jun 30, 2026

Expense ratio
2.01%$201/yr per $10k
5-yr return
−2.3%annualized
1-yr return
−7.2%as of Dec 2025
Net assets
$542.9Mall share classes
Holdings
91

Bottom line

Is MRCGX a good fund? The bottom line

MRCGX is the Class C share class of Meridian Growth Fund, an actively managed large growth mutual fund from Meridian.

Its expense ratio is 2.01% — about $201 a year on every $10,000 invested, more expensive than 97% of large growth funds we track.

It returned −7.2% over one year, −2.3% a year over five years, +6.3% a year over ten (as of Dec 31, 2025, per its prospectus).

With $543 million in net assets and 91 holdings, its largest position is Stit Govt And Agency Inst (4.2%) and the top 10 make up 24.7% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (2.01%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What MRCGX invests in

The M ERIDIAN G ROWTH F UND seeks long-term growth of capital.

The Fund attempts to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets, including the amount of any borrowings for investment purposes, in securities of growth companies. For purposes of the Funds 80% investment policy, a company is considered to be a growth company if it issues securities that are represented in a third-party growth-style index. The Fund may invest in companies that issue securities that are neither represented in any growth or value-style index (for example, a company that issues exclusively privately placed securities). The Fund may include such non-represented securities within the 80% test if the portfolio management team determines the company exhibits at least one growth characteristic similar to those commonly used by third-party index providers in growth classifications. Such characteristics may include…

From the fund's prospectus (filed Oct 30, 2026).

MRCGX performance

Average annual total returns
1 yr5 yr10 yr
MRCGX−7.2%−2.3%+6.3%
Large Growth median+15.2%+11.0%+14.2%

Source: Fund prospectus, as of Dec 31, 2025

Full MRCGX performance history →

What MRCGX costs

On a $10,000 investment, MRCGX's 2.01% expense ratio costs about $201 a year. The prospectus estimates $2,064 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.

See the full MRCGX fee table →

MRCGX top 10 holdings

#Holding% of fund
1Stit Govt And Agency Inst4.17%
2Rb Global Inc RBA2.49%
3Curtiss-wright Corp CW2.46%
4Axogen Inc AXGN2.43%
5Federal Signal Corp FSS2.36%
6Hinge Health Inc HNGE2.29%
7Definium Therapeutics Inc DFTX2.20%
8Veracyte Inc VCYT2.14%
9Standardaero Inc SARO2.09%
10Turning Point Brands Inc TPB2.08%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 24.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to MRCGX

More funds like MRCGX →

MRCGX FAQ

What is the expense ratio of MRCGX?
MRCGX's expense ratio is 2.01%, which works out to about $201 a year for every $10,000 invested. The prospectus estimates total costs of $2,064 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MRCGX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (2.01%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does MRCGX hold?
MRCGX's largest holdings are Stit Govt And Agency Inst (4.2%), Rb Global Inc (2.5%), Curtiss-wright Corp (2.5%), Axogen Inc (2.4%), Federal Signal Corp (2.4%). It holds 91 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MRCGX's 5-year return?
MRCGX returned −2.3% a year over the five years ending Dec 31, 2025, and +6.3% a year over ten years. Past performance does not guarantee future results.
Does MRCGX have a sales load?
No. MRCGX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages MRCGX?
MRCGX is offered by Meridian through Meridian Fund Inc.